178 related articles for article (PubMed ID: 26508082)
1. Increase in circulating sclerostin at the early stage of menopausal transition in Japanese women.
Matsui S; Yasui T; Kasai K; Keyama K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
Maturitas; 2016 Jan; 83():72-7. PubMed ID: 26508082
[TBL] [Abstract][Full Text] [Related]
2. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women.
Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Miura M; Irahara M
J Endocrinol Invest; 2006 Nov; 29(10):913-8. PubMed ID: 17185901
[TBL] [Abstract][Full Text] [Related]
3. Cognition in perimenopause: the effect of transition stage.
Weber MT; Rubin LH; Maki PM
Menopause; 2013 May; 20(5):511-7. PubMed ID: 23615642
[TBL] [Abstract][Full Text] [Related]
4. Changes in bone mass during the perimenopausal transition in naturally menopausal cynomolgus monkeys.
Kittivanichkul D; Watanabe G; Nagaoka K; Malaivijitnond S
Menopause; 2016 Jan; 23(1):87-99. PubMed ID: 26671190
[TBL] [Abstract][Full Text] [Related]
5. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
Costa AG; Walker MD; Zhang CA; Cremers S; Dworakowski E; McMahon DJ; Liu G; Bilezikian JP
J Clin Endocrinol Metab; 2013 Dec; 98(12):4736-43. PubMed ID: 24037879
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
Ishimura E; Okuno S; Ichii M; Norimine K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M
J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620
[TBL] [Abstract][Full Text] [Related]
7. Correlations of androstenediol with reproductive hormones and cortisol according to stages during the menopausal transition in Japanese women.
Kawakita T; Yasui T; Yoshida K; Matsui S; Iwasa T
J Steroid Biochem Mol Biol; 2021 Nov; 214():106009. PubMed ID: 34571175
[TBL] [Abstract][Full Text] [Related]
8. Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase.
Fischer DC; Mischek A; Wolf S; Rahn A; Salweski B; Kundt G; Haffner D
Ann Clin Biochem; 2012 Nov; 49(Pt 6):546-53. PubMed ID: 22984195
[TBL] [Abstract][Full Text] [Related]
9. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
Ardawi MS; Al-Kadi HA; Rouzi AA; Qari MH
J Bone Miner Res; 2011 Dec; 26(12):2812-22. PubMed ID: 21812027
[TBL] [Abstract][Full Text] [Related]
10. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.
Doyon A; Fischer DC; Bayazit AK; Canpolat N; Duzova A; Sözeri B; Bacchetta J; Balat A; Büscher A; Candan C; Cakar N; Donmez O; Dusek J; Heckel M; Klaus G; Mir S; Özcelik G; Sever L; Shroff R; Vidal E; Wühl E; Gondan M; Melk A; Querfeld U; Haffner D; Schaefer F;
PLoS One; 2015; 10(2):e0113482. PubMed ID: 25659076
[TBL] [Abstract][Full Text] [Related]
11. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.
Crandall CJ; Tseng CH; Crawford SL; Thurston RC; Gold EB; Johnston JM; Greendale GA
J Bone Miner Res; 2011 Apr; 26(4):840-9. PubMed ID: 20878774
[TBL] [Abstract][Full Text] [Related]
12. Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women.
Cheng Q; Tang W; Sheu TJ; Du Y; Gan J; Li H; Hong W; Zhu X; Xue S; Zhang X
Clin Chim Acta; 2016 Apr; 455():87-92. PubMed ID: 26826396
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum homocysteine and different menopausal stage.
Zhu Z; Jiang S; Li C; Liu J; Tao M
Climacteric; 2020 Feb; 23(1):59-64. PubMed ID: 31294633
[No Abstract] [Full Text] [Related]
14. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
Mirza FS; Padhi ID; Raisz LG; Lorenzo JA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1991-7. PubMed ID: 20156921
[TBL] [Abstract][Full Text] [Related]
15. Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition.
Tani A; Yasui T; Matsui S; Kato T; Kunimi K; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
Cytokine; 2013 Apr; 62(1):86-90. PubMed ID: 23490412
[TBL] [Abstract][Full Text] [Related]
16. Circulating sclerostin levels in relation to nutritional status, sex hormones and selected bone turnover biochemical markers levels in peri- and postmenopausal women.
Czajkowska M; Plinta R; Owczarek A; Olszanecka-Glinianowicz M; Skrzypulec-Plinta V
Ginekol Pol; 2019; 90(7):371-375. PubMed ID: 31392705
[TBL] [Abstract][Full Text] [Related]
17. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.
Ardawi MS; Rouzi AA; Qari MH
J Clin Endocrinol Metab; 2012 Oct; 97(10):3691-9. PubMed ID: 22865898
[TBL] [Abstract][Full Text] [Related]
18. Effects of estradiol-drospirenone on menopausal symptoms, lipids and bone turnover in Chinese women.
Li M; Wang A; Hu L; Song Z; Zhao Y; Sun Y; Yan L; Li X
Climacteric; 2015 Apr; 18(2):214-8. PubMed ID: 25362969
[TBL] [Abstract][Full Text] [Related]
19. Follicle stimulating hormone and its rate of change in defining menopause transition stages.
Sowers MR; Zheng H; McConnell D; Nan B; Harlow S; Randolph JF
J Clin Endocrinol Metab; 2008 Oct; 93(10):3958-64. PubMed ID: 18647816
[TBL] [Abstract][Full Text] [Related]
20. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
